SENSIMED AG

[ Editor's note: Two devices that received CE marks in Europe were initially left off this week's list. The approvals, for XtreemPulse's PureFlow counterpulsation system and Abbott's Freestyle L

Two de novo classifications were granted in March, bringing the 2016 total to three. Bio-Rad Laboratories Inc. 's Amplicheck II assay controls and Sensimed AG 's Sensimed Triggerfish intra

The worldwide glaucoma market, worth over $4 billion annually, has been dominated for decades by drug therapy, which accounts for approximately 95% of the total market. The emergence of a high-growth

IN VITRO DIAGNOSTICS Advanced Cell Diagnostics Inc. Advanced Cell Diagnostics raises $12mm through Series B round Advanced Cell Diagnostics Inc. (ACD; molecular pathology) has raised $12mm fro